文献速递糖尿病

β细胞特异性PAK1富集通过促进胰岛素生成并减少β细胞凋亡改善小鼠饮食诱导的葡萄糖不耐受

Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
PubMed 文献 · Diabetologia · 2024-10-15

在2型糖尿病患者胰岛中PAK1表达减少,急性恢复PAK1可恢复胰岛素分泌功能。本研究在小鼠中验证β细胞特异性PAK1富集能否通过增加功能性β细胞质量缓解高脂饮食诱导的葡萄糖不耐受,结果显示可增强葡萄糖耐量、增加胰岛胰岛素含量并减少β细胞凋亡。

要点

  • 在2型糖尿病患者胰岛中β细胞特异性富集PAK1可减少β细胞凋亡并增加胰岛素含量。
  • PAK1通过增强PDX1和NEUROD1与INS启动子结合,以葡萄糖响应方式促进胰岛素基因转录。
  • 多西环素诱导的β细胞特异性PAK1表达小鼠在高脂饮食下表现出增强的葡萄糖耐量、增加的胰岛胰岛素含量和减少的β细胞凋亡。

核心结论

  • PAK1在β细胞中发挥有益作用,通过增强PDX1、NEUROD1和INS表达促进胰岛素生成并具有抗凋亡效应,最终增加体内胰岛素含量和β细胞质量,改善饮食诱导的葡萄糖不耐受。

研究设计与样本

  • 使用在β细胞中表达外源PAK1的人胰岛进行bulk RNA-seq;使用过表达myc标签PAK1的人EndoC-βH1细胞进行染色质免疫沉淀(ChIP)和ChIP测序(ChIP-seq)。
  • 构建新型多西环素诱导的β细胞特异性PAK1表达(iβPAK1-Tg)小鼠,在诱导前喂食45%高脂饮食3周,随后加或不加多西环素诱导继续喂食3周,评估GTT、ITT、6小时空腹血浆胰岛素和血糖、体成分、胰岛胰岛素含量和凋亡。

主要发现

  • 在2型糖尿病人类胰岛中β细胞特异性富集PAK1导致β细胞凋亡减少和胰岛素含量增加。
  • RNA-seq显示PAK1上调INS基因转录;PAK1蛋白定位于细胞质和细胞核。
  • ChIP研究显示核内PAK1以葡萄糖响应方式增强胰腺和十二指肠同源盒1(PDX1)和神经元分化1(NEUROD1)与INS启动子的结合。
  • 与未加多西环素诱导的iβPAK1-Tg小鼠相比,高脂饮食加多西环素诱导的iβPAK1-Tg小鼠表现出增强的葡萄糖耐量、增加的胰岛胰岛素含量和减少的β细胞凋亡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: p21 (CDC42/RAC1) activated kinase 1 (PAK1) is depleted in type 2 diabetic human islets compared with non-diabetic human islets, and acute PAK1 restoration in the islets can restore insulin secretory function ex vivo. We hypothesised that beta cell-specific PAK1 enrichment in vivo can mitigate high-fat-diet (HFD)-induced glucose intolerance by increasing the functional beta cell mass. METHODS: Human islets expressing exogenous PAK1 specifically in beta cells were used for bulk RNA-seq. Human EndoC-βH1 cells overexpressing myc-tagged PAK1 were used for chromatin immunoprecipitation (ChIP) and ChIP-sequencing (ChIP-seq). Novel doxycycline-inducible beta cell-specific PAK1-expressing (iβPAK1-Tg) mice were fed a 45% HFD pre-induction for 3 weeks and for a further 3 weeks with or without doxycycline induction. These HFD-fed mice were evaluated for GTT, ITT, 6 h fasting plasma insulin and blood glucose, body composition, islet insulin content and apoptosis. RESULTS: Beta cell-specific PAK1 enrichment in type 2 diabetes human islets resulted in decreased beta cell apoptosis and increased insulin content. RNA-seq showed an upregulation of INS gene transcription by PAK1. Using clonal human beta cells, we found that PAK1 protein was localised in the cytoplasm and the nucleus. ChIP studies revealed that nuclear PAK1 enhanced pancreatic and duodenal homeobox1 (PDX1) and neuronal differentiation 1 (NEUROD1) binding to the INS promoter in a glucose-responsive manner. Importantly, the iβPAK1-Tg mice, when challenged with HFD and doxycycline induction displayed enhanced glucose tolerance, increased islet insulin content and reduced beta cell apoptosis when compared with iβPAK1-Tg mice without doxycycline induction. CONCLUSIONS/INTERPRETATION: PAK1 plays an unforeseen and beneficial role in beta cells by promoting insulin biogenesis via enhancing the expression of PDX1, NEUROD1 and INS, along with anti-apoptotic effects, that culminate in increased insulin content and beta cell mass in vivo and ameliorate diet-induced glucose intolerance. DATA AVAILABILITY: The raw and processed RNA-seq data and ChIP-seq data, which has been made publicly available at Gene Expression Omnibus (GEO) at https://www.ncbi.nlm.nih.gov/geo/ , can be accessed in GSE239382.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ahn M, Dhawan S, McCown EM, et al. Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis. Diabetologia. 2024. PMID: 39404845. doi:10.1007/s00125-024-06286-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。